| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |